False Claims Act Enforcement by the DOJ

The False Claims Act (FCA) is the federal government's primary statutory tool for recovering funds lost to fraud against government programs. Enforced principally by the DOJ Civil Division and U.S. Attorneys' offices nationwide, the FCA imposes civil liability on individuals and entities that submit false or fraudulent claims for federal payment. This page covers the statute's scope, enforcement mechanics, evidentiary thresholds, classification distinctions, and the persistent tensions that define FCA litigation.

• Definition and scope
• Core mechanics or structure
• Causal relationships or drivers
• Classification boundaries
• Tradeoffs and tensions
• Common misconceptions
• Checklist or steps (non-advisory)
• Reference table or matrix

Definition and scope

The False Claims Act, codified at 31 U.S.C. §§ 3729–3733, imposes civil liability on any person who knowingly presents, or causes to be presented, a false or fraudulent claim for payment or approval to the federal government. Liability also attaches for false records or statements material to a false claim, for reverse false claims (concealing obligations to repay the government), and for conspiring to commit any of the foregoing acts.

The statute covers a broad sweep of federal expenditure: Medicare and Medicaid reimbursements, defense procurement contracts, federal grant disbursements, federally backed mortgage insurance, and customs duties. Any program funded in whole or in part by federal dollars falls within the statute's reach. The DOJ's Civil Fraud Section, housed within the DOJ Civil Division, coordinates national FCA enforcement priorities alongside the 94 U.S. Attorneys' offices that litigate cases in their respective districts.

Per the DOJ's own annual reporting, FCA recoveries since the 1986 amendments to the statute have exceeded $75 billion in total (DOJ FCA Statistics), making it the single most productive civil fraud recovery mechanism in federal law.

Core mechanics or structure

FCA enforcement proceeds through two distinct channels: government-initiated actions and qui tam actions brought by private relators.

Government-initiated actions begin when a federal agency or the DOJ's own investigators develop sufficient evidence of fraud, often following an audit by the agency's Office of Inspector General, a referral from the DOJ Inspector General, or parallel criminal investigation.

Qui tam actions allow private individuals—referred to as relators—to file suit on behalf of the government under seal. During the seal period, which the statute sets at a minimum of 60 days under 31 U.S.C. § 3730(b)(2), DOJ investigates and decides whether to intervene. Government intervention dramatically increases recovery probability; non-intervened cases are litigated by the relator's private counsel alone.

The penalty structure under the FCA as adjusted for inflation under the Federal Civil Penalties Inflation Adjustment Act includes a per-claim civil penalty range, which DOJ periodically updates. As of the 2023 adjustment, the per-claim penalty range is $13,946 to $27,894 (DOJ Civil Penalties Inflation Adjustment), plus treble damages—meaning the government recovers three times the amount of actual damages sustained.

Relators who file valid qui tam suits are entitled to a share of the recovery: between 15 and 25 percent when DOJ intervenes, and between 25 and 30 percent when the relator proceeds without government intervention (31 U.S.C. § 3730(d)).

A Civil Investigative Demand (CID) is a key pre-litigation tool. The DOJ may issue CIDs to compel production of documents, answers to interrogatories, and oral testimony from persons believed to possess information relevant to a false claims investigation, without first filing suit.

Causal relationships or drivers

The surge in FCA litigation volume after the 1986 amendments is directly traceable to three structural changes Congress enacted: raising the government's damage multiplier from double to treble damages, expanding the definition of "knowingly" to include deliberate ignorance and reckless disregard, and strengthening the qui tam relator share and anti-retaliation provisions.

The expansion of Medicare and Medicaid spending over subsequent decades enlarged the pool of potential FCA defendants. Healthcare fraud now accounts for the majority of FCA recoveries in any given fiscal year. In FY 2023, healthcare fraud settlements and judgments totaled approximately $1.8 billion of the $2.68 billion in total FCA recoveries (DOJ FCA Statistics FY 2023).

Defense procurement fraud constitutes the second-largest category. The DOJ Criminal Division frequently runs parallel criminal investigations alongside civil FCA matters, creating compounded exposure for defendants and incentivizing early resolution.

DOJ enforcement priorities also drive volume. Policy memoranda directing U.S. Attorneys' offices to prioritize healthcare, pandemic relief fraud (under programs such as the Paycheck Protection Program), and cybersecurity compliance claims have corresponded with measurable upticks in case filings in those sectors. The DOJ's corporate enforcement policy influences how organizational defendants weigh cooperation against litigation risk.

Classification boundaries

Not every improper government payment triggers FCA liability. The statute requires proof of four elements: (1) a false statement or fraudulent course of conduct; (2) made with the requisite scienter (knowledge, deliberate ignorance, or reckless disregard); (3) that was material to the government's payment decision; and (4) caused the government to pay out money it would not otherwise have paid.

The materiality standard, clarified by the Supreme Court in Universal Health Services, Inc. v. United States ex rel. Escobar, 579 U.S. 176 (2016), requires that the false statement have a natural tendency to influence, or be capable of influencing, the government's payment decision. A regulatory violation that the government routinely overlooked or continued to pay despite knowing of the violation is unlikely to satisfy materiality.

The FCA does not cover:

• Tax fraud (addressed by separate IRS enforcement channels)
• State-only program fraud where no federal funds are implicated
• Mere breach of contract without a false representation
• Negligent billing errors that lack scienter

These classification lines matter because defendants frequently argue that billing disputes or regulatory noncompliance constitute contract or administrative law issues rather than fraud, pushing the conduct outside FCA reach.

Tradeoffs and tensions

The FCA's qui tam mechanism creates a structural tension between maximizing fraud detection and managing litigation quality. Because relators receive a percentage of recoveries, the statute incentivizes filings that may be speculative, duplicative, or parasitic on prior government investigations. The first-to-file bar under 31 U.S.C. § 3730(b)(5) blocks subsequent relators from filing related actions once an initial qui tam suit is pending, but does not eliminate the filing of marginally distinct claims.

The public disclosure bar, amended in 2010 by the Affordable Care Act, limits qui tam suits based on fraud already publicly disclosed in specified government or news media channels unless the relator qualifies as an "original source." Courts interpret the scope of this bar differently across circuits, creating forum-dependent litigation risk.

A separate tension exists in the materiality standard post-Escobar. Defendants argue that aggressive materiality arguments by DOJ undermine settled billing practices, while relators and the government argue that narrowing materiality insulates pervasive fraud from accountability.

The anti-retaliation provision (31 U.S.C. § 3730(h)) protects employees, contractors, and agents who engage in protected activity from harassment, suspension, or termination. The scope of "protected activity" has generated a circuit split on whether internal reporting—as opposed to formal government reporting—qualifies, affecting whistleblower protections available to potential relators.

Common misconceptions

Misconception: The FCA applies only to intentional fraud.
The statute's "knowingly" definition explicitly encompasses deliberate ignorance and reckless disregard for truth. Willful blindness to billing irregularities is sufficient for liability; proof of specific intent to defraud is not required.

Misconception: Settling an FCA case is an admission of liability.
DOJ settlement agreements in FCA matters routinely include language stating that the defendant does not admit the allegations as a condition of resolution. Settlement avoids the treble damages and per-claim penalties of a litigated judgment, not an admission of wrongdoing.

Misconception: The government must directly receive the false claim.
Claims submitted to federally funded programs—even if processed by state agencies or private insurers acting as fiscal intermediaries—fall within the FCA if federal funds are implicated in the payment chain. The DOJ healthcare fraud enforcement program relies heavily on this indirect claim theory.

Misconception: A relator can file a qui tam action against any company they suspect of wrongdoing.
The relator must possess independent knowledge of the fraud—not merely a theory derived from public sources. The "original source" requirement and public disclosure bar exist precisely to filter out opportunistic filings lacking genuine insider knowledge.

Checklist or steps (non-advisory)

The following describes the procedural sequence of a qui tam FCA action from filing through resolution. This is a factual description of the process, not legal guidance.

1. Relator files complaint under seal in the appropriate federal district court, accompanied by a written disclosure statement providing all material evidence and information (31 U.S.C. § 3730(b)(2)).
2. DOJ receives case referral from the court and initiates investigation, typically in coordination with the relevant agency's Office of Inspector General.
3. Seal period begins at a statutory minimum of 60 days; DOJ routinely seeks extensions from the court, often running 1 to 3 years for complex healthcare or defense fraud matters.
4. DOJ issues Civil Investigative Demands as needed to obtain documents, interrogatory responses, and testimony from targets or witnesses.
5. DOJ makes intervention decision: elect to intervene (taking over litigation), decline to intervene (relator may proceed independently), or move to dismiss on government interest grounds.
6. Complaint is unsealed and served on defendant upon intervention decision or court order.
7. Litigation or settlement negotiation proceeds: if the government intervenes, DOJ leads settlement discussions; if not, relator's counsel leads.
8. Recovery allocated: after resolution, relator share is calculated per statutory formula; DOJ attorneys' fees and costs may be sought from defendant.
9. Judgment or consent decree entered, with treble damages and applicable per-claim penalties assessed if the matter proceeds to judgment.

The broader framework of how the DOJ approaches enforcement strategy across civil and criminal matters is covered at /index.

Reference table or matrix